CDC authorizes COVID-19 vaccines for children 5-11 years of age

Author

Image of Blaire-Bryant.jpg

Blaire Bryant

Legislative Director, Health | Large Urban County Caucus

Upcoming Events

Conference

NACo AI South Regional Forum

Conference

2025 NACo Legislative Conference

Related News

Image of GettyImages-1315887649.jpg

Key Takeaways

On November 2, the Centers for Disease Control and Prevention (CDC) approved the use of COVID-19 vaccines for children aged 5-11 following the Food and Drug Administration’s (FDA) recommendation. The CDC’s endorsement follows the FDA’s recommendation on October 29 to authorize emergency use of the Pfizer-BioNTech COVID-19 vaccine to include children 5-11 years of age.

The FDA’s decision comes after it was determined the vaccine was approximately 91 percent effective in preventing COVID-19 in children 5-11 years of age. Children within this age group account for 39 percent of COVID-19 cases in individuals younger than 18 years of age across the nation. An ongoing study discovered no serious side effects in approximately 3,100 children aged 5-11 who received the COVID-19 vaccine.

On October 14, the CDC released a Pediatric COVID-19 Vaccination Operational Planning Guide, which highlights key differences between adult and adolescent vaccination programs and those that are designed for children. The National Association of County and City Health Officials (NACCHO) has provided a summary of the guide and pulled out high-level considerations for county health departments, as key components of pediatric COVID-19 vaccination planning in local communities.

As key providers of local public health services and frontline service providers for the medically vulnerable, counties have supported over 192 million vaccinations in the United States to date and will continue to play an essential role in the administration of COVID-19 vaccines and boosters. For more information on how county health facilities can prepare for the distribution of COVID-19 vaccines for children, and COVID-19 boosters, see NACo’s COVID-19 Vaccine Distribution Toolkit.

ADDITIONAL RESOURCES

Tagged In:

Related News

Doctor with tablet and patient
Advocacy

HRSA Releases Final Reentry Care Guidelines Following NACo Input

On November 29, the Health Resources and Services Administration (HRSA) released their final Policy Information Notice (PIN) with policy guidance for health centers who support transitions in care for justice-involved individuals reentering their communities. 

Image of GettyImages-898373354_boomers_rgb.jpg
Advocacy

U.S. Senate Committee approves legislation to reauthorize programs for older adults

On July 31, the U.S. Senate Committee on Health, Employment, Labor and Pensions (HELP) approved the bipartisan Older Americans Act Reauthorization Act of 2024 on a 20-1 vote. 

public health
County News

Health does not have to be partisan: Talking about health in a way that resonates with everyone

The de Beaumont Foundation has identified tangible steps county officials can take to heal divides and talk about community health in a way that resonates with everyone.